Fagron

From local player to global market leader and consolidator in the market of pharmaceutical compounding in only 20 years.

Fagron was founded in Rotterdam (the Netherlands) in 1990 by Ger van Jeveren. Through a continuous focus on innovation, quality and solution-oriented thinking, Ger van Jeveren brought market leadership in pharmaceutical compounding to Fagron in the Netherlands in just 7 years.

Ger van Jeveren continued to direct further development and international growth, with the result that Fagron is currently the global market leader and active in 30 countries in Europe, the Americas, Africa, the Middle East, Asia, and the Pacific. Fagron products are sold to 200,000 customers in over 60 countries around the world. Over 200 Fagron pharmacists are continually developing new, unique products and concepts to meet the growing worldwide need for tailor-made medication.

Market leadership provides major competitive advantages, such as the central procurement of raw materials, optimal utilization of production facilities, and the international roll-out of successful and innovative products and concepts. With over 1,600 employees, Fagron generated a turnover of € 335 million in 2013.

Fagron intends to further reinforce its worldwide market leadership based on an active buy-and-build strategy, starting up greenfields and robust organic growth.

Fagron mission and strategy

Fagron’s strategy is focused on optimizing and innovating customized pharmaceutical care in order to widen the therapeutic options of prescribers worldwide. As a R&D scientific specialty pharma company, we are supporting the unique selling point of customized medication and improving patients’ quality of life. 

As the leading company in specialty pharma, Fagron develops innovative concepts and solutions that respond to the specific and individual wishes of compounding pharmacies all over the world. In Fagron’s Innovation department, over 300 pharmacists are dedicated to developing and providing innovative concepts, products and formulas that will meet the demands of the pharmacist, prescriber and patient.

Fagron is active in the following segments of Specialty Pharma:

  • Fagron Specialty Pharma Services: Customized medication that is prepared in Fagron’s 22 sterile, nuclear and non-sterile compounding facilities in Europe, North America, South America and South Africa.
  • Fagron Trademarks: Innovative concepts, vehicles and formulations for specialty pharma that are developed by Fagron's R&D team, often in close cooperation with prescribers, pharmacies and universities.
  • Fagron Essentials: Pharmaceutical raw materials, equipment and supplies that pharmacists need in order to be able to prepare medication in the pharmacy.
 

Fagron, Inc. - USA

Fagron, Inc., is headquartered in St. Paul, Minnesota. The company has continued to grow through the years because of its innovation and ability to bring new products to the U.S. compounding market.

Since 1980, Fagron, Inc. has been a US Food and Drug Administration-registered pharmaceutical supplier, adhering strictly to current Good Manufacturing Practices (cGMP). Bulk Pharmaceutical Ingredients (BPI) are purchased from reputable, registered, and validated manufacturers. Incoming BPIs are initially quarantined, then sampled and tested for identity, strength, quality, and purity in our Quality Control Laboratories, using methods as set forth in the applicable monographs of USP, NF, British Pharmacopoeia (BP), or European Pharmacopoeia (EP). Repackaging is performed in our climate-monitored facility, then retested by Quality Control (QC) and reviewed by Quality Assurance (QA) before release to the market. Fagron, Inc. has been VAWD accredited since 2012 and is committed to preventing counterfeit, contaminated or diverted drugs from entering the United States drug supply. VAWD accreditation ensures that our distribution facility operates legitimately, is licensed in good standing, and is employing security and best practices for safely distributing prescription drugs. More about Fagron’s unique quality process can be found here.